Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Commercialisé
Current status date:
2009-08-04
Original market date: See footnote 1
2002-02-16
Product name:
DEFINITY
DIN:
02243173
Product Monograph/Veterinary Labelling:
Date:
2022-09-09
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
LANTHEUS MI CANADA INC
1111 Dr. Frederik-Philips Blvd., Suite 600
Montreal
QUÉBEC
CANADA
H4M 2X6
Class:
Humain
Dosage form(s):
Suspension
Route(s) of administration:
Intraveineuse
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
36:89.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
V08DA04 MICROSPHERES OF PHOSPHOLIPIDS
Active ingredient group (AIG) number:See footnote5
0142602001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| Perflutrène | 150 MCL / ML |